On Tuesday, Legend Biotech Corp ADR (NASDAQ: LEGN) was 1.33% up from the session before settling in for the closing price of $33.85. A 52-week range for LEGN has been $27.34 – $60.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 0.79%. When this article was written, the company’s average yearly earnings per share was at 12.78%. With a float of $181.38 million, this company’s outstanding shares have now reached $184.03 million.
Let’s determine the extent of company efficiency that accounts for 2609 employees. In terms of profitability, gross margin is 65.51%, operating margin of -32.49%, and the pretax margin is -27.11%.
Legend Biotech Corp ADR (LEGN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Legend Biotech Corp ADR stocks. The insider ownership of Legend Biotech Corp ADR is 1.44%, while institutional ownership is 46.74%. The most recent insider transaction that took place on Jun 24 ’25, was worth 408,600. Before that another transaction happened on Jun 24 ’25, when Company’s Director proposed sale 307 for $34.37, making the entire transaction worth $10,552.
Legend Biotech Corp ADR (LEGN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 12.78% per share during the next fiscal year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
You can see what Legend Biotech Corp ADR (LEGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.19, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach 0.65 in one year’s time.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
Looking closely at Legend Biotech Corp ADR (NASDAQ: LEGN), its last 5-days average volume was 1.53 million, which is a jump from its year-to-date volume of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 20.63%.
During the past 100 days, Legend Biotech Corp ADR’s (LEGN) raw stochastic average was set at 54.98%, which indicates a significant increase from 52.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.14% in the past 14 days, which was higher than the 55.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.36, while its 200-day Moving Average is $37.80. However, in the short run, Legend Biotech Corp ADR’s stock first resistance to watch stands at $35.06. Second resistance stands at $35.81. The third major resistance level sits at $36.56. If the price goes on to break the first support level at $33.56, it is likely to go to the next support level at $32.81. Should the price break the second support level, the third support level stands at $32.06.
Legend Biotech Corp ADR (NASDAQ: LEGN) Key Stats
There are 183,763K outstanding shares of the company, which has a market capitalization of 6.31 billion. As of now, sales total 627,240 K while income totals -177,030 K. Its latest quarter income was 195,050 K while its last quarter net income were -100,920 K.
